Search Results 721-730 of 21430 for anti-TNF drugs

1. Progestin Contraceptives (Oral Route, Parenteral Route) Description and Brand Names - Mayo Clinic

   Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Aygestin; Camila; Errin; Jolivette; Lyza ...

2. Escitalopram (Oral Route) Precautions - Mayo Clinic

   These may be symptoms of a serious condition called serotonin syndrome. The risk may be higher if you or your child also take certain other medicines that ...

3. Tretinoin (Topical Route) Precautions - Mayo Clinic

   Precautions · For patients using tretinoin for the treatment of acne: Regular use of water-based creams or lotions helps to reduce skin irritation or dryness ...

4. Ide-cel, a BCMA-directed CAR-T cell therapy, shows favorable risk-benefit profile and response - Mayo Clinic

   A phase 1 study finds low incidence of severe side effects and high response rate for ide-cel, an anti-BCMA CAR-T cell therapy for relapsed or refractory ...

5. Capecitabine and Bevacizumab With or Without Atezolizumab in Treating Patients With Refractory Metastatic Colorectal Cancer - Mayo Clinic

   Drugs used in chemotherapy, such as capecitabine ... anti-EGFR antibody (if tumor is RAS wild-type) ... TNF] agents) =< 14 days prior to randomization ...

6. Flecainide (Oral Route) Before Using - Mayo Clinic

   Studies in women suggest that this medication poses minimal risk to the infant when used during breastfeeding. Drug Interactions. Although certain medicines ...

7. Antipyrine And Benzocaine (Otic Route) Description and Brand Names - Mayo Clinic

   Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. AB Otic; Aurodex; Auroto; Benzotic; Dec-Agesic AB; Dolotic ...

8. Ethinyl Estradiol And Norelgestromin (Transdermal Route) Before Using - Mayo Clinic

   An alternative to this medication should be prescribed or you should stop breastfeeding while using this medicine. Drug Interactions. Although certain medicines ...

9. New treatment option for early type 1 diabetes - Mayo Clinic

   According to findings published in The New England Journal of Medicine in 2023, teplizumab is an anti-CD3 antibody approved for people 8 years and older ...

10. Tuberous sclerosis - Diagnosis and treatment - Mayo Clinic

    Medicine. Anti-seizure medicines may be prescribed to control seizures. Other medicines may help manage heart rhythm problems, behavior problems or other ...